title: Nanobodies as novel agents for disease diagnosis and therapy.
abstract: The discovery of naturally occurring, heavy-chain only antibodies in Camelidae, and their further development into small recombinant nanobodies, presents attractive alternatives in drug delivery and imaging. Easily expressed in microorganisms and amenable to engineering, nanobody derivatives are soluble, stable, versatile, and have unique refolding capacities, reduced aggregation tendencies, and high-target binding capabilities. This review outlines the current state of the art in nanobodies, focusing on their structural features and properties, production, technology, and the potential for modulating immune functions and for targeting tumors, toxins, and microbes.
authors.affiliation: Department of Industrial Management and Technology, University of Piraeus, Piraeus, Greece.
authors.forename: Christina G
authors.initials: CG
authors.lastname: Siontorou
mesh_terms: D000818:Animals; D002162:Camelus; D016503:Drug Delivery Systems; D007143:Immunoglobulin Heavy Chains; D057054:Molecular Imaging; D050997:Nanomedicine; D061905:Single-Domain Antibodies
chemical_list: D007143:Immunoglobulin Heavy Chains; D061905:Single-Domain Antibodies
keywords: antibody expression; formatting; heavy chain antibodies; molecular display; nanobodies